top of page

Nucleic Acid Immunity Meeting 2022

September 22 - 24, 2022

Royal College of Physicians of Edinburgh - RCPE

Edinburgh, UK

It was a pleasure to reconvene in person for the second conference of the Nucleic Acid Immunity Meeting Series in Edinburgh in 2022 after the pandemic hiatus. Hosting the event at the Royal College of Physicians of Edinburgh (RCPE) added a distinguished touch to our gathering, emphasizing the significance of resuming face-to-face interactions. We're grateful for the opportunity to reconnect and collaborate once again.

2022.10.23_HGU1429_NAI-Meeting-2022_1000x653.jpg

NAIM22 Participants in the Old College Quad at the Wayfair Library in Edinburgh, UK

Foto: TRR237

Program Features

Relive the highlights from our extraordinary conference! Explore the dynamic program that showcased groundbreaking research on Nucleic Acid Immunity. Dive into the heart of insightful abstracts showcasing the collaborative research shared at this conference, making it truly exceptional. Stay tuned for our future conferences and more exciting opportunities to engage with cutting-edge research and experts in the field of Nucleic Acid Immunity!

2.5 days

93 Participants

(limited attendance due to COVID-19 restrictions)

3 Keynote Lectures

20 Invited Speakers

11 Short Talks

30 Posters

2 Poster Sessions

For more detailed information please scroll down on this page.

Our Speakers

We express our sincere appreciation to the three keynote speakers, the 20 invited speakers, and the 11 short talk speakers of the Nucleic Acid Immunity Meeting 2022 - NAIM22. Your invaluable insights and expertise have been instrumental in shaping this conference, rendering it truly outstanding.

Keynotes
  • Andrea Ablasser, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland

  • Zhijian 'James' Chen, University of Texas Southwestern Medical Center, Dallas, USA

  • Raphaela Goldbach-Mansky, NIH National Institute of Allergy and Infectious Diseases, Bethesda, USA

 
Invited Speakers
  • Dusan Bogunovic, Icahn School of Medicine at Mount Sinai, New York, USA

  • Hana Cahova, Institute of Organic Chemistry and Biochemistry of the CAS, Prague, Czech Republic

  • Roger Greenberg, University of Pennsylvania, Philadelphia, USA

  • Veit Hornung, LMU Gene Center Munich, Germany

  • Hiroki Kato, Institute of Cardiovascular Immunology, University Hospital Bonn, Germany

  • Philip Kranzusch, Dana-Farber Cancer Institute, Harvard Medical School, USA

  • Elke Krüger, University of Greifswald, Germany

  • Min Ae Lee-Kirsch, University Hospital Carl Gustav Carus, TU Dresden, Germany

  • Pingwei Li, Texas A&M University, USA

  • John Maciejowski, Memorial Sloan Kettering Cancer Center, New York, USA

  • Nicolas Manel, Institut Curie, Paris, France

  • Kensuke Miyake, University of Tokyo, Japan

  • Carina de Oliveira Mann, Institute of Virology, TU Munich, Germany

  • Agnel Sfeir, Memorial Sloan Kettering Cancer Center, New York, USA

  • Dan Stetson, University of Washington, Seattle, USA

  • Stephen Tait, Cancer Research UK Beatson Institute, Glasgow, UK

  • Phillip West, Texas A&M University College of Medicine, USA

  • Nan Yan, University of Texas Southwestern Medical Center, Dallas, USA

 
Short Talk Speakers
  • Stefan Bauer, Institute of Immunology, Marburg, Germany

  • Olivia Majer, Max Planck Institute for Infection Biology, Berlin, Germany

  • Liam Keegan, Central European Institute of Technology, Bro, Czech Republic

  • Katherine Balka, Anatomy and Developmental Biology, Clayton, Australia

  • Richard de Reuver, VIB Center for Inflammation Research, Gent, Belgium

  • Alberto Ciccia, Columbia University Irving Medical Center, New York, USA

  • Rayk Behrendt, Institute of Clinical Chemistry and Clinical Pharmacology, Bonn, Germany

  • Andreas Pichlmair, Institute of Virology, Munich, Germany

  • Axel Roers, Institute of Immunology, Heidelberg, Germany

  • Eva Bartok, Institute of Experimental Hematology and Transfusion Medicine, Bonn, Germany

  • Trine H. Mogensen, Department of Biomedicine, Aarhus, Denmark

  • Manuele Rebsamen, Department of Biochemistry, Lausanne, Switzerland

  • Thomas Zillinger, Institute of Clinical Chemistry and Clinical Pharmacology, Bonn. Germany

Our Team of Organizers

The Nucleic Acid Immunity Meeting 2022 was expertly organized by a stellar team, including local luminaries Yanick Crow and Andrew Jackson, alongside Gunther Hartmann, speaker of TRR237 at the time. Their collaborative vision and dedication resulted in an exceptional conference experience, catalyzing innovation and collaboration within the realm of Nucleic Acid Immunity.

Organizers

Coordinators
  • Margaret MacDonald, MRC Human Genetics Unit, Edinburgh, UK

  • Simon Görgen, TRR237, University Hospital Bonn, Bonn, German

NAIM22 Gallery

Relive the vibrant moments of NAIM22 through our curated gallery of photos.

From engaging keynote sessions to dynamic discussions, each snapshot captures the essence of our unforgettable gathering. Join us in reminiscing the shared experiences and cherished memories that made this conference truly special.

bottom of page